ClinicalTrials.gg
Sign In

Drug

Ocifisertib fumarate clinical trials

Also written CFI-400945.

studies test it
6
open now
1
in phase 3
0
first study started
2014

Keep track of what changes. Save the ocifisertib fumarate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

CFI-400945
6

Studies by the year they started

6 studies that test it; most in 2018 (2)

Studies that test ocifisertib fumarate, by start year
YearStudies
20141
20182
20191
20201
20231

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
4

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms
3
Prostatic Neoplasms
1
Leukemia, Myeloid, Acute
1
Neoplasms
1

Who runs them

Industry 0 · Other 6

Canadian Cancer Trials Group (4) · University Health Network, Toronto (2)

Often tested with

Tested in the same studies.

Durvalumab (1) · Adavosertib (1) · Savolitinib (1) · Darolutamide (1) · Ipatasertib (1) · Durvalumab/Tremelimumab Regimen (1) · Carboplatin (1) · Lunresertib (1)

Studies

Open first, then newest update. How each study uses ocifisertib fumarate is read from its arms, and is right about nine times in ten.

Testing it · 6

Given in every arm · 1 — ocifisertib fumarate is usual care beside what is tested

Codes

What other systems call ocifisertib fumarate · ClinicalTrials.gg INT000090

  • UNII (FDA) 09OB3E5QTDOCIFISERTIB FUMARATEOne source FDA
  • NCI Thesaurus C111990Ocifisertib FumarateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.